Filing Details
- Accession Number:
- 0001179110-15-013364
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-09-28 16:56:08
- Reporting Period:
- 2015-09-24
- Filing Date:
- 2015-09-28
- Accepted Time:
- 2015-09-28 16:56:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1436304 | Kythera Biopharmaceuticals Inc | KYTH | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1573074 | Frederick Iii Beddingfield | C/O Kythera Biopharmaceuticals 30930 Russell Ranch Road, Suite 300 Westlake Village CA 91362 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-09-24 | 96,875 | $22.49 | 96,875 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-09-24 | 13,763 | $44.02 | 110,638 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-09-24 | 110,638 | $74.91 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options | Disposition | 2015-09-24 | 46,875 | $0.00 | 46,875 | $22.49 |
| Common Stock | Stock Options | Disposition | 2015-09-24 | 50,000 | $0.00 | 50,000 | $22.49 |
| Common Stock | Stock Options | Disposition | 2015-09-24 | 13,763 | $0.00 | 13,763 | $44.02 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 28,125 | 2023-04-01 | No | 4 | M | Direct | |
| 0 | 2023-04-01 | No | 4 | M | Direct | |
| 19,266 | 2024-01-22 | No | 4 | M | Direct |
Footnotes
- 25% of the shares subject to the option vested on the first anniversary measured from January 1, 2012 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
- The shares subject to these options vested 100% upon the achievement of certain performance milestones approved by the Issuer's Board of Directors.
- The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $74.90 to $74.95, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Billionaire Hedge Funds
